Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 25 | 75 | 150 | 0 | 16 |
| Gross Profit | 25 | 75 | 150 | N/A | 16 |
| Operating Expenses | 29,328 | 30,685 | 33,163 | 26,150 | 25,958 |
| Operating Income | -29,303 | -30,610 | -33,013 | -26,150 | -25,942 |
| Other Income | 257 | 237 | 318 | 83 | 14 |
| Pre-tax Income | -29,046 | -30,373 | -32,695 | -26,067 | -25,928 |
| Net Income Continuous | -29,046 | -30,373 | -32,695 | -26,067 | -25,928 |
| Net Income | $-29,046 | $-30,373 | $-32,695 | $-26,067 | $-25,928 |
| EPS Basic Total Ops | -12.14 | -12.74 | -13.79 | -11.09 | -12.14 |
| EPS Basic Continuous Ops | -12.19 | -12.75 | -13.73 | -11.07 | -12.17 |
| EPS Diluted Total Ops | -12.14 | -12.74 | -13.79 | -11.09 | -12.14 |
| EPS Diluted Continuous Ops | -12.19 | -12.75 | -13.73 | -11.07 | -12.17 |
| EBITDA(a) | $-28,691 | $-29,918 | $-32,272 | $-25,783 | $-25,808 |